CTRI/2024/03/064592招募中3 期
Efficacy of Plasma Exchange Therapy vs Standard Medical Therapy in Severe Alcoholic Hepatitis With High Discriminant Function- A Randomized Controlled Trial. - NI
试验速览
- 阶段
- 3 期
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Age 18 to 60 years
- •2.Severe alcoholic hepatitis with DFmore than 80 and less than 120 or MELD more than 30
- •3.No liver transplant option available in near future(for atleast 1 month)
- •4.Patient able to bear the cost of Plasma exchange by himself/herself
排除标准
- •1.Active sepsis
- •2.S creatinine more than 1.5mg per dl
- •3.Chronic kidney disease
- •4.Pregnancy
- •5.HCC or any other malignancy
- •6.Active Bleeding
- •7.Allergic to replacement fluid (FFP) in TPE
- •8.Severe Hypocalcemia (less than 7.6 mg per dl)
- •9.Failure to give consent
- •10.Financial issues to bear cost of Plasma exchange
研究者
相似试验
已完成
不适用
COST EFFECTIVENESS IN TREATING GUILLAIN BARRE SYNDROME PATIENTS WITH INTRAVENOUS IMMUNOGLOBULIN AS COMPARED TO THERAPEUTIC PLASMA EXCHANGECTRI/2018/04/013278Department of Transfusion Medicine PGIMER40
招募中
不适用
Is therapeutic plasma exchange a better treatment than intravenous immunoglobulin in people with severe Guillain-Barre Syndrome (GBS)?ACTRN12621000815864Waikato Hospital50
尚未招募
3 期
se of plasma exchange in patients with alcoholic liver failureCTRI/2019/04/018349Rekha Hans
尚未招募
不适用
A Study to find out the effect of blood purification (replacing the liquid part of blood) in improving the survival of children with severe infection and organ failureCTRI/2021/07/035316Intramural Research Fund JIPMER
已完成
2 期
Efficacy of Combined Convalescent Plasma Therapy with Oral RNA-dependent RNA Polymerase Inhibitor versus Monoclonal Neutralizing Antibody Therapy among Mild to Moderate COVID-19 in Outpatients: Multicenter, Non-inferiority, Open-label Randomized Controlled TrialMild to moderate COVID-19 (non-severe COVID-19)COVID-19, SARS-CoV-2, favipiravir, sotrovimab, convalescent plasma therapy, monoclonal neutralizing antibodyTCTR20220319002Chulabhorn Royal Academy136
